Table 2.
Model 1: MANCOVA Results | |||
---|---|---|---|
Structure | Parameter | t-value | p-value |
L anterolateral entorhinal | Age Dose*duration Gender |
.459 .410 −2.472 |
.648 .683 .016 |
R anterolateral entorhinal | Age Dose*duration Gender |
.030 −1.182 −.875 |
.976 .241 .384 |
L posteromedial entorhinal | Age Dose*duration Gender |
.152 .614 −1.127 |
.879 .541 .263 |
R posteromedial entorhinal | Age Dose*duration Gender |
.079 −.015 .585 |
.937 .988 .560 |
L perirhinal | Age Dose*duration Gender |
1.124 −.416 −3.522 |
.265 .679 .001 |
R perirhinal | Age Dose*duration Gender |
.591 −.521 −2.524 |
.556 .604 .014 |
L parahippocampal | Age Dose*duration Gender |
−.188 −.258 −1.450 |
.851 .797 .151 |
R parahippocampal | Age Dose*duration Gender |
−.504 −.710 −1.514 |
.616 .480 .134 |
L DG/CA3 | Age Dose*duration Gender |
−1.816 −2.234 −.976 |
.073 .028 .332 |
R DG/CA3 | Age Dose*duration Gender |
−.119 −2.255 −.491 |
.906 .027 .625 |
L CA1 | Age Dose*duration Gender |
−.075 −1.849 −3.040 |
.941 .068 .003 |
R CA1 | Age Dose*duration Gender |
.912 −1.550 −2.292 |
.365 .125 .025 |
L subiculum | Age Dose*duration Gender |
−1.539 .715 −3.179 |
.128 .477 .002 |
R subiculum | Age Dose*duration Gender |
−.090 −.751 −2.259 |
.928 .455 .027 |